$2.67T
Total marketcap
$46.73B
Total volume
BTC 49.89%     ETH 17.08%
Dominance

Doseology Sciences Inc. MOOD.CN Stock

0.32 CAD {{ price }} -13.513515% {{change_pct}}%
COUNTRY
Canada
Market Cap
1.41M CAD
LOW - HIGH [24H]
0.32 - 0.32 CAD
VOLUME [24H]
4.25K CAD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.34 CAD

Doseology Sciences Inc. Price Chart

Doseology Sciences Inc. MOOD.CN Financial and Trading Overview

Doseology Sciences Inc. stock price 0.32 CAD
Previous Close 0.03 CAD
Open 0 CAD
Bid 0.03 CAD x N/A
Ask 0.04 CAD x N/A
Day's Range 0 - 0 CAD
52 Week Range 0 - 0.1 CAD
Volume 0 CAD
Avg. Volume 14.16K CAD
Market Cap 1.23M CAD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.34 CAD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

MOOD.CN Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Doseology Sciences Inc. Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -62.50%
S&P500 52-Week Change 20.43%
52 Week High 0.1 CAD
52 Week Low 0 CAD
50-Day Moving Average 0.04 CAD
200-Day Moving Average 0.04 CAD

MOOD.CN Share Statistics

Avg. Volume (3 month) 14.16K CAD
Avg. Daily Volume (10-Days) 5.15K CAD
Shares Outstanding 41.1M
Float N/A
Short Ratio 0.03
% Held by Insiders 17.88%
% Held by Institutions 0%
Shares Short 263
Short % of Float N/A
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq) N/A
Next Fiscal Year End N/A

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.03
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Doseology Sciences Inc.

Country Canada
State BC
City Kelowna
Address 406-460 Doyle Avenue
ZIP V1Y 0C2
Phone N/A
Website https://doseology.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Doseology Sciences Inc. engages in the cultivation and extraction of nutraceutical and pharmaceutical products in Canada. It focuses on research, development, and sale of medicinal mushroom products, including tinctures and powders. The company sells its products online through doseology.com. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.

Q&A For Doseology Sciences Inc. Stock

What is a current MOOD.CN stock price?

Doseology Sciences Inc. MOOD.CN stock price today per share is 0.32 CAD.

How to purchase Doseology Sciences Inc. stock?

You can buy MOOD.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Doseology Sciences Inc.?

The stock symbol or ticker of Doseology Sciences Inc. is MOOD.CN.

Which industry does the Doseology Sciences Inc. company belong to?

The Doseology Sciences Inc. industry is Biotechnology.

How many shares does Doseology Sciences Inc. have in circulation?

The max supply of Doseology Sciences Inc. shares is 4.4M.

What is Doseology Sciences Inc. Price to Earnings Ratio (PE Ratio)?

Doseology Sciences Inc. PE Ratio is now.

What was Doseology Sciences Inc. earnings per share over the trailing 12 months (TTM)?

Doseology Sciences Inc. EPS is -0.34 CAD over the trailing 12 months.

Which sector does the Doseology Sciences Inc. company belong to?

The Doseology Sciences Inc. sector is Healthcare.